Curating a Strong Financial Case to Gain Approval to Run a Hybrid Clinical Trial From Internal Executives Within The Company
Time: 9:00 am
day: Day One
Details:
- Showcasing strategies to demonstrate financial gain and provide a thorough risk-management assessment
- Scalability and evidence generation with DCTs
- Strategies used to decide which elements should be decentralized in a hybrid setting
